allergy and anaphylaxis australia

What allergy and anaphylaxis australia does

Allergy & Anaphylaxis Australia (A&AA) is a registered Australian charity and ACNC-registered non-profit headquartered in Baulkham Hills, NSW, that serves as the peak national body for allergy and anaphylaxis awareness, education, and advocacy. Its operations centre on a community-led information platform addressing approximately 1.9 million Australians living with food allergy, including people with allergies across all life stages and their parents, carers, and family members, as well as secondary audiences of health professionals, schools and childcare services, food service operators, and first aid providers. The core offering is an evidence-based content library — real-time food allergen alerts, a bi-monthly Allergy News email newsletter, a National Allergy Helpline (1300 728 000), free eating-out and management guides, an Understanding Allergy Care Hub, and licensable training animations covering EpiPen and Anapen administration and the signs and symptoms of allergic reactions — supplemented by trainer devices for adrenaline auto-injectors sold through an online shop.

A&AA's technical footprint is information- and content-centric rather than platform-centric: the website (allergyfacts.org.au) functions as the primary distribution surface for resources, food alerts, and the online shop, with no disclosed APIs, SDKs, applications, or proprietary software platforms. Distribution extends through email newsletter, social media, a phone helpline, and a licensing programme that embeds training animations into the learning management systems of schools, childcare providers, first aid trainers, and food service organisations.

The business model is a diversified non-profit revenue stack rather than a single pricing model: Australian Government funding channelled through the National Allergy Council partnership with ASCIA, a multi-tier corporate sponsorship programme (Diamond sponsors CSL Seqirus, Arrotex/Anapen, Sanofi, and Viatris; Platinum DBV Technologies; Gold Nutricia and Biocelect; Silver Cocobella and Novartis; in-kind Clayton UTZ), individual donations and fundraising, advertising on website and email, sales of trainer devices and educational materials, paid consultancy to food manufacturers and service organisations, paid allergen-update communications from manufacturers to subscribers, annual licensing fees on training animations, and referral income from third-party links. Pricing for consultancy and licensing is negotiated individually and is not publicly disclosed.

Name

allergy and anaphylaxis australia

Legal name

Allergy & Anaphylaxis Australia

Website

https://allergyfacts.org.au

Company type

Private

Operating status

Operating

Short description

Allergy & Anaphylaxis Australia is a registered Australian charity that provides allergy information, education, resources, advocacy, and a National Allergy Helpline to people with allergies, their carers, health professionals, schools, and food service operators across Australia.

Ownership category

akta.pro rank

Product category

Allergy and Anaphylaxis Health Support Services

NAICS

Individual and Family Services (6241)

SIC

Services-Health Services (8000)

akta.pro primary industry

Food Allergy Evaluation & Management (HLAKAAAD)

akta.pro secondary industries

Pediatric Allergy & Immunology (HLAKAAAB), Food Allergy Management & Special Diet Support (EDACAMAG)

Keywords

• Allergy support services
• Anaphylaxis education
• Health advocacy
• Community health information
• Nonprofit health charity

Headquarters

HQ city

Baulkham Hills

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Sponsorships and Grants: As a registered charity, A&AA relies on sponsorships and grants (general or specific to a resource, program, or activity) as a core revenue stream. Sponsorships and grants complement other revenue streams.
2. Fundraising Activities: The organisation conducts fundraising activities to generate revenue.
3. Advertising: A&AA generates advertising revenue through sponsored social media posts, website news, and email content. Advertisements for therapeutic goods comply with the therapeutic goods advertising code.
4. Donations: Individual donor contributions collected through the website and fundraising campaigns.
5. Sales of Educational Materials: Revenue from sales of educational resources and materials including trainer devices for adrenaline auto-injectors (EpiPen, Anapen).
6. Professional Consultancy Services: A&AA provides advice and expertise about life with allergic disease to sponsors, partners, and others including food manufacturers, food service organisations, children's services, schools, and pharmaceutical companies. Companies are charged a fee to communicate allergen ingredient changes to subscribers and social media followers. Food recall information from regulatory sources is communicated free of charge.
7. Licensing of Materials: Organisations may licence materials such as animations (How to Give an EpiPen, How to Give an Anapen, Signs and Symptoms) for embedding in their own learning management systems, for a small annual licence fee.
8. Referral Income: A&AA may earn referral income from links to third-party organisations on the A&AA website, including from apps.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Allergy & Anaphylaxis Australia is a national not-for-profit charity that delivers allergy information, education, advocacy, and direct support services to Australians living with allergies and at risk of anaphylaxis. Its core offerings include a national helpline, food allergen alerts, educational animations, allergy training devices, the Allergy Care Hub online resource, a newsletter, and an eating-out guide, complemented by consultancy, licensing of materials, and sponsorship-funded awareness programs for the broader community, health professionals, food service, and education sectors.

Product overview

Allergy & Anaphylaxis Australia operates as a charitable health organization providing education, awareness, and support services for Australians living with allergic disease. The organization offers a portfolio of information resources including real-time food allergen alerts, educational animations and videos (available for licensing), trainer devices for adrenaline auto-injectors, and a comprehensive Understanding Allergy Care Hub. These resources are distributed through a subscription-based newsletter, a national helpline, and a network of corporate sponsors representing the pharmaceutical and food industries. The core offering is educational rather than a commercial product platform, focused on improving quality of life for those affected by allergies through evidence-based information and emergency preparedness resources.

Differentiator

Problem solved

Functional benefit

Products and services

• National Allergy Helpline A national phone and email helpline providing allergy information, advice, and emotional support to individuals, families, and carers affected by allergies and anaphylaxis across Australia.
• Food Allergen Alerts A subscription-based alert service that notifies subscribers about food recalls and allergen-related product warnings relevant to people with food allergies.
• Allergy Care Hub An online resource hub providing allergy information, educational content, and practical guidance for individuals, families, and health professionals managing allergies.
• Educational Animations Library A library of educational animations explaining allergy and anaphylaxis concepts, licensed for use by health professionals, schools, and food service operators for training and patient education.
• Allergy Trainer Devices Trainer devices (including EpiPen-style trainers) sold to consumers, schools, and first aid providers to support practice and training in adrenaline auto-injector use.
• A&AA Newsletter A recurring email newsletter delivering allergy updates, allergen alerts, advocacy news, and organizational updates to subscribers across Australia.
• Eating Out Guide A consumer and industry-facing guide that supports people with allergies when dining out, licensed and promoted for use by food service operators.
• Consultancy and Advisory Services Paid consultancy and advisory services delivered to government bodies, food service operators, schools, and pharmaceutical sponsors on allergy policy, training, and consumer engagement.
• Licensed Educational Materials Licensing of A&AA's allergy educational content, animations, and resources for use by schools, childcare providers, food service operators, and health organizations under commercial license.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• National Allergy CouncilcoreStrategic or Co-development PartnerThe National Allergy Council is a partnership between Allergy & Anaphylaxis Australia and the Australasian Society of Clinical Immunology and Allergy (ASCIA). A&AA is supported by funding from the Australian Government, Department of Health, Disability and Ageing via the National Allergy Council. The partnership aims to improve quality of life for Australians with allergic disease.
• Australasian Society of Clinical Immunology and Allergy (ASCIA)coreStrategic or Co-development PartnerASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. Together with A&AA, ASCIA co-leads the National Allergy Council, which receives Australian Government funding for allergy initiatives.
• Food Standards Australia New ZealandminorOthersA&AA receives food recall and allergen update information from Food Standards Australia New Zealand via state food authorities, which is communicated free of charge to subscribers.

Scale indicators2 records

Recent moves2 records

Expansion highlights4 records

Direct peers

• Allergy UK: National UK charity providing allergy information, support, and advocacy for people with allergic disease. Closest international equivalent to A&AA in mission and operating model, providing patient-facing allergy education, helpline support, and corporate sponsorship from pharmaceutical and food manufacturers.
• Food Allergy Research & Education (FARE): Largest US-based food allergy patient advocacy organisation, providing education, research funding, advocacy, and community support. Directly comparable to A&AA in its patient-focused mission, food allergy specialisation, and reliance on corporate sponsorship and donations.
• Anaphylaxis Campaign: UK charity dedicated to supporting people at risk of severe allergic reactions, providing training resources, helpline services, and advocacy. Closely aligned with A&AA's anaphylaxis-specific focus, including adrenaline device training and educational animations licensed to organisations.
• Allergy & Asthma Network: US nonprofit focused on allergy and asthma patient education, advocacy, and outreach. Comparable to A&AA in serving patients across the allergy disease spectrum, providing physician-reviewed resources, and operating multi-channel engagement including newsletters and helpline support.
• Allergy New Zealand: New Zealand patient advocacy charity for people with allergic disease. Operates as a national peak body analogous to A&AA, with similar mission of education, support, and advocacy, and comparable dependence on sponsorships and donations.
• Kids With Food Allergies (KFA): US-based division of the Asthma and Allergy Foundation of America focused specifically on paediatric food allergy. Comparable to A&AA's child-focused resources, including infant feeding guidance, school allergy management, and family support programmes.

Emerging players

• Australasian Society of Clinical Immunology and Allergy (ASCIA): Peak professional body for clinical immunology and allergy in Australia and New Zealand. ASCIA is A&AA's strategic partner through the National Allergy Council and provides the medical/scientific content authority behind A&AA's evidence-based resources.
• National Allergy Council Australia: Government-funded partnership between A&AA and ASCIA that delivers national allergy initiatives. Functions as a closely related entity rather than a competitor, but represents the institutional channel through which A&AA's strategic direction is increasingly shaped.

Regional players

• Asthma Australia: Australian national charity focused on asthma education and support, with significant overlap in respiratory and allergic disease patient populations. Comparable community-led operating model, multi-channel engagement, and pharmaceutical sponsorship structure to A&AA.
• Eczema Association of Australasia: Australian patient support organisation for eczema (atopic dermatitis), which A&AA actively covers in its resources. Comparable nonprofit model addressing a related allergic disease with overlapping pharmaceutical sponsor base (e.g., Sanofi, which markets Dupixent for eczema).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/allergy-anaphylaxis-australia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about allergy and anaphylaxis australia